• investor network: vascular biogenics ltd. to host earnings call ACCESS Newswire Thu, 27 Feb 2025 16:22:29 GMT
• biogenic polymer based patches for congenital cardiac surgery: future development of implants Frontiers Thu, 27 Feb 2025 08:00:00 GMT
• Biogenic polymer based patches for congenital cardiac surgery: future development of implants Frontiers Wed, 26 Feb 2025 08:00:00 GMT
• thyroid cancer drugs market on track of significant expansion by 2031 | biovista, vascular biogenics, azaya EIN News Wed, 22 Jan 2025 13:35:00 GMT
• vbl therapeutics announces proposed public offering of 2.5 mln shares of ordinary shares Reuters.com Sat, 16 Nov 2024 08:00:00 GMT
• glioblastoma multiforme (gbm) treatment market size, analysis, overview, outlook by 2024-2033 WhaTech Fri, 04 Oct 2024 07:00:00 GMT
• vbl therapeutics announces radiographic analysis of vb-111 phase 2 and 3 clinical trials in recurrent glioblastoma shows survival ... Marketscreener.com Thu, 03 Oct 2024 07:39:02 GMT
• notable labs, ltd. announces plan to initiate volasertib phase 2 program in the coming months Marketscreener.com Tue, 27 Aug 2024 07:33:59 GMT
• notable labs, ltd. announces change of chief executive officer Marketscreener.com Mon, 26 Aug 2024 20:05:00 GMT
• who are the leading innovators in oncolytic viral proteins for the pharmaceutical industry? Pharmaceutical Technology Tue, 30 Jul 2024 07:00:00 GMT
• who are the leading innovators in oncolytic adenovirus vectors for the pharmaceutical industry? Pharmaceutical Technology Tue, 30 Jul 2024 07:00:00 GMT
• hypoxia inducible factor 1 alpha inhibitor industry forecast: predictions for the coming years TIMC Wed, 24 Jul 2024 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates infi, hrzn, vblt Marketscreener.com Sun, 14 Jul 2024 05:47:37 GMT
• vascular biogenics (vblt) reports q4 loss, lags revenue estimates Yahoo New Zealand News Sun, 23 Jun 2024 21:36:23 GMT
• hypoxia inducible factor 1 alpha inhibitor market analysis to 2030 | inc., casi pharmaceuticals inc., cerulean pharma ... PrimePair Thu, 20 Jun 2024 11:07:11 GMT
• vascular biogenics (vblt) reports q4 loss, lags revenue estimates Yahoo New Zealand News Thu, 20 Jun 2024 04:56:00 GMT
• vascular biogenics (vblt) reports q3 loss, lags revenue estimates Yahoo Movies UK Tue, 28 May 2024 05:29:21 GMT
• how much is vascular biogenics ltd. (nasdaq:vblt) paying its ceo? Yahoo Movies Canada Sun, 19 May 2024 10:03:02 GMT
• vascular biogenics (vblt) reports q4 loss, tops revenue estimates Yahoo Singapore News Sun, 19 May 2024 04:00:57 GMT
• vascular biogenics (vblt) reports q2 loss, misses revenue estimates Yahoo News UK Fri, 17 May 2024 14:13:45 GMT
• vascular biogenics (vblt) reports q2 loss, misses revenue estimates Yahoo News UK Tue, 14 May 2024 20:48:40 GMT
• how much is vascular biogenics ltd. (nasdaq:vblt) paying its ceo? Yahoo Movies Canada Tue, 14 May 2024 12:58:50 GMT
• vascular biogenics (vblt) reports q3 loss, lags revenue estimates Yahoo Lifestyle Australia Tue, 14 May 2024 12:10:32 GMT
• vascular biogenics ltd. (nasdaq:vblt) analysts just slashed next year's revenue estimates by 16% Yahoo Movies UK Mon, 13 May 2024 10:46:55 GMT
• vascular biogenics (vblt) reports q2 loss, misses revenue estimates Yahoo News UK Sun, 12 May 2024 04:06:34 GMT
• vascular biogenics (vblt) reports q4 loss, tops revenue estimates Yahoo Singapore News Tue, 07 May 2024 10:00:27 GMT
• vascular biogenics ltd. (nasdaq:vblt) analysts just slashed next year's revenue estimates by 16% Yahoo Movies UK Mon, 06 May 2024 07:09:12 GMT
• vascular biogenics ltd. (nasdaq:vblt) analysts just slashed next year's revenue estimates by 16% Yahoo Movies UK Sun, 05 May 2024 12:00:01 GMT
• vascular biogenics ltd. (nasdaq:vblt) analysts just slashed next year's revenue estimates by 16% Yahoo Movies UK Tue, 30 Apr 2024 11:23:16 GMT
• we think vascular biogenics (nasdaq:vblt) can afford to drive business growth Yahoo Movies UK Fri, 26 Apr 2024 10:27:27 GMT
• vascular biogenics (vblt) reports q3 loss, lags revenue estimates Yahoo Movies UK Thu, 18 Apr 2024 02:55:22 GMT
• this just in: analysts are boosting their vascular biogenics ltd. (nasdaq:vblt) outlook for this year Yahoo Movies UK Tue, 16 Apr 2024 13:55:56 GMT
• vbl therapeutics to participate in the jefferies healthcare conference GuruFocus.com Tue, 16 Apr 2024 09:29:28 GMT
• q3 2021 vascular biogenics ltd earnings call transcript GuruFocus.com Thu, 08 Feb 2024 07:26:19 GMT
• q1 2021 vascular biogenics ltd earnings call transcript GuruFocus.com Thu, 08 Feb 2024 07:26:12 GMT
• vascular biogenics ltd kol event on ovarian cancer transcript GuruFocus.com Thu, 08 Feb 2024 07:26:06 GMT
• jmp securities cuts notable labs' price target to $9 from $13, keeps market outperform rating Marketscreener.com Tue, 19 Dec 2023 17:41:04 GMT
• notable labs, ltd. and ciclomed llc announces initial safety and efficacy data of fosciclopirox and the performance ... Marketscreener.com Mon, 18 Dec 2023 13:00:00 GMT
• ventas del mercado global inhibidor alfa del factor 1 inducible por ... La Voz de Valparaíso Tue, 05 Dec 2023 12:07:00 GMT
• keay nakae's buy rating on notable labs: predictive precision medicine platform and financial stability as key factors Markets Insider Mon, 20 Nov 2023 08:00:00 GMT
• vblt - vascular biogenics ltd. latest stock news & market updates StockTitan Sun, 19 Nov 2023 00:01:31 GMT
• who are the leading innovators in gene therapy viral vectors for the ... Pharmaceutical Technology Wed, 15 Nov 2023 08:00:00 GMT
• who are the leading innovators in oncolytic adenovirus vectors for ... Pharmaceutical Technology Wed, 15 Nov 2023 08:00:00 GMT
• notable labs announces filing of form 10-q for third quarter 2023 StreetInsider.com Tue, 14 Nov 2023 21:15:16 GMT
• vascular biogenics (nasdaq:vblt) now covered by analysts at stocknews.com Defense World Mon, 13 Nov 2023 08:00:00 GMT
• zurich insurance's acquisition of majority stake in kotak mahindra ... Global Legal Chronicle Fri, 03 Nov 2023 00:00:00 GMT
• vascular biogenics (vblt) price target increased by 160.00% to 13.26 Nasdaq Wed, 01 Nov 2023 07:00:00 GMT
• first-line pembrolizumab + chemotherapy versus placebo + ... ASCO Journals Wed, 01 Nov 2023 07:00:00 GMT
• le marché des inhibiteurs alpha du facteur 1 inductible par l'hypoxie ... Bigouden.Tv Sun, 29 Oct 2023 15:35:08 GMT
• principal financial group (nyse:pfg) shares gap up following ... Defense World Sat, 28 Oct 2023 07:00:00 GMT
• der markt für hypoxie-induzierbare faktor-1-alpha-inhibitoren wird ... EKZ CrossTour Thu, 26 Oct 2023 11:37:49 GMT
• clinical trial links oncolytic immunoactivation to survival in ... Nature.com Wed, 18 Oct 2023 07:00:00 GMT
• Notable Labs Closes Merger Transaction With VBL Therapeutics GlobeNewswire Mon, 16 Oct 2023 07:00:00 GMT
• vbl therapeutics announces results of annual and special shareholder meeting Yahoo Finance Thu, 12 Oct 2023 07:00:00 GMT
• why avidity biosciences shares are trading higher by around 9%: 20 stocks moving premarket markets.businessinsider.com Mon, 09 Oct 2023 07:00:00 GMT
• vbl therapeutics reminds shareholders to vote in the upcoming ... BioSpace Wed, 04 Oct 2023 07:00:00 GMT
• rano 2.0: update to the response assessment in neuro-oncology ... ASCO Journals Fri, 29 Sep 2023 07:00:00 GMT
• today's biggest pre-market stock movers: 10 top gainers and ... InvestorPlace Thu, 21 Sep 2023 07:00:00 GMT
• inaugural results of the individualized screening trial of innovative ... ASCO Journals Mon, 18 Sep 2023 07:00:00 GMT
• VBL Therapeutics Announces that S-4 Registration Statement GlobeNewswire Wed, 06 Sep 2023 07:00:00 GMT
• oral selinexor as maintenance therapy after first-line ... ASCO Journals Tue, 05 Sep 2023 07:00:00 GMT
• vascular biogenics investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates merger of vascu... Financial Content Mon, 28 Aug 2023 07:00:00 GMT
• vbl therapeutics reports second quarter 2023 financial results and provides business update StockTitan Mon, 14 Aug 2023 07:00:00 GMT
• thyroid cancer drugs market set for remarkable growth: coverage ... Yahoo Finance Mon, 14 Aug 2023 07:00:00 GMT
• cineworld's financial restructuring – global legal chronicle Global Legal Chronicle Sat, 05 Aug 2023 07:00:00 GMT
• global thyroid cancer drugs market to reach $1.29 billion by 2027 ... GlobeNewswire Mon, 31 Jul 2023 07:00:00 GMT
• glioblastoma multiforme (gbm) treatment global market 2023 revenues and share analysis report with forecast to openPR Tue, 11 Jul 2023 07:00:00 GMT
• Biogenic polymer-based patches for congenital cardiac surgery: a feasibility study Frontiers Wed, 21 Jun 2023 07:00:00 GMT
• pembrolizumab added to chemotherapy improves survival in advanced cervical cancer regardless of pd-l1 expression The ASCO Post Sat, 10 Jun 2023 07:00:00 GMT
• who are the leading innovators in nanorobotics for the technology ... Verdict Tue, 06 Jun 2023 07:00:00 GMT
• who are the leading innovators in viral vectors for the ... Pharmaceutical Technology Mon, 05 Jun 2023 07:00:00 GMT
• global glioblastoma multiforme (gbm) treatment market report ... Yahoo Finance Tue, 16 May 2023 07:00:00 GMT
• global thyroid cancer drugs market report 2023: increasing focus ... Yahoo Finance Tue, 09 May 2023 07:00:00 GMT
• lenvatinib plus pembrolizumab in previously treated advanced ... ASCO Journals Fri, 14 Apr 2023 07:00:00 GMT
• dabrafenib plus trametinib in brafv600e-mutated rare cancers: the ... Nature.com Fri, 14 Apr 2023 07:00:00 GMT
• evaluation of standard response assessment in neuro-oncology ... ASCO Journals Fri, 07 Apr 2023 07:00:00 GMT
• achieving optimal health through transdermal magnesium therapy Acupuncture Today Sun, 02 Apr 2023 22:31:57 GMT
• vascular biogenics full year 2022 earnings: us$0.42 loss per share (vs us$0.45 loss in fy 2021) Yahoo Finance Fri, 17 Mar 2023 07:00:00 GMT
• vbl therapeutics announces closing of sale of manufacturing facility and certain related assets for $7.1 million in ... Yahoo Finance Thu, 09 Mar 2023 08:00:00 GMT
• aleph farms increases production capabilities with vbl ... Business Wire Wed, 01 Mar 2023 08:00:00 GMT
• moore kuehn encourages ptrs, vblt, indt, and jnce investors to contact law firm GlobeNewswire Tue, 28 Feb 2023 08:00:00 GMT
• shareholder investigation: halper sadeh llc investigates rocc, bte, admp, vblt Marketscreener.com Tue, 28 Feb 2023 08:00:00 GMT
• today’s biggest pre-market stock movers: 10 top gainers and losers on friday InvestorPlace Fri, 24 Feb 2023 08:00:00 GMT
• why beyond meat shares are trading higher by 14%; here are 20 stocks moving premarket markets.businessinsider.com Fri, 24 Feb 2023 08:00:00 GMT
• VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement GlobeNewswire Thu, 23 Feb 2023 08:00:00 GMT
• shareholder investigation: halper sadeh llc investigates infi, hrzn, vblt PR Newswire Thu, 23 Feb 2023 08:00:00 GMT
• vblt stock rises on all-stock merger deal with notable labs (nasdaq:vblt) Seeking Alpha Thu, 23 Feb 2023 08:00:00 GMT
• vascular biogenics rises 85% on all-stock merger deal with notable labs Seeking Alpha Thu, 23 Feb 2023 08:00:00 GMT
• vbl therapeutics announces agreement to sell manufacturing GlobeNewswire Thu, 16 Feb 2023 08:00:00 GMT
• who are the leading innovators in gene therapy delivery using viral ... Pharmaceutical Technology Thu, 16 Feb 2023 08:00:00 GMT
• vascular biogenics ltd (vblt) stock declines 0.00% this week; should you buy? InvestorsObserver Fri, 02 Dec 2022 08:00:00 GMT
• las acciones israelíes se tambalean al borde de wall street Noticias de Israel Fri, 21 Oct 2022 07:00:00 GMT
• le 1001 azioni che si sono schiantate sul mercato azionario usa Scenari Economici Wed, 19 Oct 2022 07:00:00 GMT
• identification of patients with ovarian cancer experiencing the ... ASCO Journals Mon, 17 Oct 2022 07:00:00 GMT
• the 1001 imploded stocks of 2022 (down 80% or more)… so far WOLF STREET Mon, 17 Oct 2022 07:00:00 GMT
• vascular biogenics stock price today | stock price history Stocks Telegraph Fri, 30 Sep 2022 17:26:54 GMT
• a phase ii, two-stage study of letrozole and abemaciclib in ... ASCO Journals Thu, 29 Sep 2022 07:00:00 GMT
• pliant (plrx) receives positive review of ipf study at top dose Yahoo Finance Fri, 02 Sep 2022 07:00:00 GMT
• axsome (axsm) starts late-stage study of migraine drug axs-07 Nasdaq Fri, 02 Sep 2022 07:00:00 GMT
• vbl therapeutics announces second quarter 2022 financial results and corporate process to explore strategic ... GlobeNewswire Mon, 15 Aug 2022 07:00:00 GMT
• VB-111 Failure Raises Questions About Ovarian Cancer Immunotherapy Oncology News Central Mon, 08 Aug 2022 07:00:00 GMT
• can vascular biogenics ltd (vblt) stock rise to the top of healthcare sector thursday? InvestorsObserver Thu, 04 Aug 2022 07:00:00 GMT
• less than 2 weeks after failure-induced stock shock, vbl therapeutics lays off staff Fierce Biotech Tue, 02 Aug 2022 07:00:00 GMT
• vascular biogenics ltd (vblt) stock loses -4.35% this week; should you buy? InvestorsObserver Tue, 02 Aug 2022 07:00:00 GMT
• lo spread vola oltre 240, tassi a livello grecia e borsa in forte rosso ... Benzinga Italia Thu, 21 Jul 2022 07:00:00 GMT
• Greenlane Holdings (GNLN) Stock Price Rallied 22.5% on a $5.3M Sale AskTraders.com Wed, 20 Jul 2022 07:00:00 GMT
• vascular biogenics cut to neutral at hc wainwright after trial failure sinks stock 79% Seeking Alpha Wed, 20 Jul 2022 07:00:00 GMT
• why is vascular biogenics (vblt) stock down 80% today? InvestorPlace Wed, 20 Jul 2022 07:00:00 GMT
• panic infects vbl investors as viral therapy flunks phase 3 cancer test FierceBiotech Wed, 20 Jul 2022 07:00:00 GMT
• VBL Therapeutics Announces Top-Line Data from Phase 3 OVAL GlobeNewswire Tue, 19 Jul 2022 07:00:00 GMT
• VBL Therapeutics sinks ~75% after late-stage trial for ovarian cancer treatment fails Seeking Alpha Tue, 19 Jul 2022 07:00:00 GMT
• rucaparib maintenance improves progression-free survival in patients with newly diagnosed advanced ovarian cancer who responded to... The ASCO Post Sun, 10 Jul 2022 07:00:00 GMT
• rucaparib maintenance improves pfs in patients with newly ... The ASCO Post Sun, 10 Jul 2022 07:00:00 GMT
• protalix biotherapeutics appoints shmuel "muli" ben zvi, ph.d. to its board of directors BioSpace Thu, 30 Jun 2022 07:00:00 GMT
• atlas holdings llc's acquisition of carlex glass america, llc and ... Global Legal Chronicle Fri, 17 Jun 2022 07:00:00 GMT
• a randomized, phase iii trial to evaluate rucaparib monotherapy ... ASCO Journals Mon, 06 Jun 2022 07:00:00 GMT
• infigratinib in patients with recurrent gliomas and fgfr alterations ... Cancer Discovery Wed, 01 Jun 2022 13:06:19 GMT
• should you sell vascular biogenics ltd (vblt) in biotechnology industry? InvestorsObserver Tue, 31 May 2022 07:00:00 GMT
• radiation therapy for brain metastases: asco guideline ... ASCO Journals Fri, 13 May 2022 07:00:00 GMT
• vbl therapeutics to report first quarter 2022 financial results on may 17 GlobeNewswire Tue, 10 May 2022 07:00:00 GMT
• vbl therapeutics to participate in upcoming scientific and industry conferences in may Yahoo Finance Tue, 03 May 2022 07:00:00 GMT
• should you add vascular biogenics ltd (vblt) stock to your portfolio thursday? InvestorsObserver Thu, 28 Apr 2022 07:00:00 GMT
• vbl therapeutics stock rises 10% on fda fast track status for vb-111 for ovarian cancer Seeking Alpha Tue, 26 Apr 2022 07:00:00 GMT
• vbl therapeutics receives fda fast track designation for ofra-vec for the treatment of platinum-resistant ovarian ... Yahoo Finance Tue, 26 Apr 2022 07:00:00 GMT
• mirvetuximab soravtansine induces high response rates in platinum-resistant ovarian cancer Oncology News Central Fri, 25 Mar 2022 07:00:00 GMT
Vascular Biogenics Ltd(NASDAQ:VBLT) 
Vascular Biogenics Ltd., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for cancer and immune/inflammatory indications. The company's program is based on its proprietary vascular targeting system platform technology, which utilizes ge...
Website: http://www.vblrx.com
Founded: 2000
Full Time Employees: 38
Sector: Healthcare
Industry: Biotechnology